The key patent for Danish drugmaker Novo Nordisk's semaglutide (the active ingredient in Ozempic and Wegovy) in India expires March 20
This formulation is supplied in pre-standardised research delivery format to support consistent compound composition, controlled laboratory handling, and reproducibility across non-clinical experimental workflows
A second lower dose was tested as well to investigate a potential dose dependent effect on receptor binding
They are often most effective when used to complement a well-designed plan that includes nutritional support, movement, and ongoing accountability
If you plan to resume, restart at the full dose rather than titrating back up, since the break period allows receptor resensitization
In everyday life, diet, exercise, and structured support also play an important role